Switch to:

The Medicines Co EV-to-EBITDA

: -41.24 (As of Today)
View and export this data going back to 2000. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, The Medicines Co's enterprise value is $7,345.26 Mil. The Medicines Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was $-178.09 Mil. Therefore, The Medicines Co's EV-to-EBITDA for today is -41.24.

NAS:MDCO' s EV-to-EBITDA Range Over the Past 10 Years
Min: -221.1   Med: 11   Max: 221.5
Current: -41.24

-221.1
221.5

During the past 13 years, the highest EV-to-EBITDA of The Medicines Co was 221.50. The lowest was -221.10. And the median was 11.00.

NAS:MDCO's EV-to-EBITDA is ranked lower than
99.99% of the 652 Companies
in the Drug Manufacturers industry.

( Industry Median: 15.19 vs. NAS:MDCO: -41.24 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-09-25), The Medicines Co's stock price is $84.90. The Medicines Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-3.10. Therefore, The Medicines Co's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


The Medicines Co EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

The Medicines Co Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.17 -30.15 26.49 -3.94 -8.42

The Medicines Co Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.85 -8.42 -14.37 -19.29 -25.49

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


The Medicines Co EV-to-EBITDA Distribution

* The bar in red indicates where The Medicines Co's EV-to-EBITDA falls into.



The Medicines Co EV-to-EBITDA Calculation

The Medicines Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=7345.258/-178.089
=-41.24

The Medicines Co's current Enterprise Value is $7,345.26 Mil.
The Medicines Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was -33.674 (Dec. 2018 ) + -43.337 (Mar. 2019 ) + -43.759 (Jun. 2019 ) + -57.319 (Sep. 2019 ) = $-178.09 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


The Medicines Co  (NAS:MDCO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

The Medicines Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=84.90/-3.1
=

The Medicines Co's share price for today is $84.90.
The Medicines Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was -0.58 (Dec. 2018 ) + -0.8 (Mar. 2019 ) + -0.8 (Jun. 2019 ) + -0.92 (Sep. 2019 ) = $-3.10.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


The Medicines Co EV-to-EBITDA Related Terms


The Medicines Co EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)